TY - JOUR
T1 - Advanced MR Techniques for Preoperative Glioma Characterization
T2 - Part 2
AU - Hangel, Gilbert
AU - Schmitz-Abecassis, Bárbara
AU - Sollmann, Nico
AU - Pinto, Joana
AU - Arzanforoosh, Fatemehsadat
AU - Barkhof, Frederik
AU - Booth, Thomas
AU - Calvo-Imirizaldu, Marta
AU - Cassia, Guilherme
AU - Chmelik, Marek
AU - Clement, Patricia
AU - Ercan, Ece
AU - Fernández-Seara, Maria A.
AU - Furtner, Julia
AU - Fuster-Garcia, Elies
AU - Grech-Sollars, Matthew
AU - Guven, N. Tugay
AU - Hatay, Gokce Hale
AU - Karami, Golestan
AU - Keil, Vera C.
AU - Kim, Mina
AU - Koekkoek, Johan A.F.
AU - Kukran, Simran
AU - Mancini, Laura
AU - Nechifor, Ruben Emanuel
AU - Özcan, Alpay
AU - Ozturk-Isik, Esin
AU - Piskin, Senol
AU - Schmainda, Kathleen M.
AU - Svensson, Siri F.
AU - Tseng, Chih Hsien
AU - Unnikrishnan, Saritha
AU - Vos, Frans
AU - Warnert, Esther
AU - Zhao, Moss Y.
AU - Jancalek, Radim
AU - Nunes, Teresa
AU - Hirschler, Lydiane
AU - Smits, Marion
AU - Petr, Jan
AU - Emblem, Kyrre E.
N1 - Publisher Copyright:
© 2023 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.
PY - 2023/6
Y1 - 2023/6
N2 - Preoperative clinical MRI protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas. The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation. This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques. In this second part, we review magnetic resonance spectroscopy (MRS), chemical exchange saturation transfer (CEST), susceptibility-weighted imaging (SWI), MRI-PET, MR elastography (MRE), and MR-based radiomics applications. The first part of this review addresses dynamic susceptibility contrast (DSC) and dynamic contrast-enhanced (DCE) MRI, arterial spin labeling (ASL), diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting (MRF). Evidence Level: 3. Technical Efficacy: Stage 2.
AB - Preoperative clinical MRI protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas. The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation. This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques. In this second part, we review magnetic resonance spectroscopy (MRS), chemical exchange saturation transfer (CEST), susceptibility-weighted imaging (SWI), MRI-PET, MR elastography (MRE), and MR-based radiomics applications. The first part of this review addresses dynamic susceptibility contrast (DSC) and dynamic contrast-enhanced (DCE) MRI, arterial spin labeling (ASL), diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting (MRF). Evidence Level: 3. Technical Efficacy: Stage 2.
KW - GliMR 2.0
KW - brain
KW - contrasts
KW - glioma
KW - level of clinical validation
KW - preoperative
UR - http://www.scopus.com/inward/record.url?scp=85150601586&partnerID=8YFLogxK
U2 - 10.1002/jmri.28663
DO - 10.1002/jmri.28663
M3 - Review article
C2 - 36912262
AN - SCOPUS:85150601586
SN - 1053-1807
VL - 57
SP - 1676
EP - 1695
JO - Journal of Magnetic Resonance Imaging
JF - Journal of Magnetic Resonance Imaging
IS - 6
ER -